NCT02016482View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail Psoriasis

PHASE3CompletedINTERVENTIONAL
Enrollment

217

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

April 30, 2016

Conditions
Nail PsoriasisPlaque Psoriasis
Interventions
BIOLOGICAL

Adalimumab

OTHER

Placebo

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY